Evaxion Biotech AS (EVAX)
3.95
+0.06
(+1.54%)
USD |
NASDAQ |
May 03, 16:00
3.95
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Price: 3.95 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 3.90 | 3.99 | 3.85 | 3.95 | 16026.00 |
May 02, 2024 | 4.05 | 4.05 | 3.89 | 3.89 | 7567.00 |
May 01, 2024 | 4.16 | 4.16 | 3.91 | 3.91 | 3741.00 |
Apr 30, 2024 | 4.13 | 4.20 | 4.07 | 4.17 | 9644.00 |
Apr 29, 2024 | 4.31 | 4.31 | 4.059 | 4.29 | 16494.00 |
Apr 26, 2024 | 4.25 | 4.33 | 4.02 | 4.18 | 25104.00 |
Apr 25, 2024 | 4.11 | 4.13 | 3.85 | 4.12 | 7185.00 |
Apr 24, 2024 | 4.18 | 4.18 | 4.05 | 4.13 | 10156.00 |
Apr 23, 2024 | 4.28 | 4.28 | 3.99 | 4.14 | 25028.00 |
Apr 22, 2024 | 4.36 | 4.36 | 4.19 | 4.19 | 9891.00 |
Apr 19, 2024 | 4.24 | 4.410 | 4.170 | 4.31 | 30943.00 |
Apr 18, 2024 | 4.11 | 4.248 | 4.11 | 4.22 | 35375.00 |
Apr 17, 2024 | 4.10 | 4.15 | 3.93 | 4.11 | 29921.00 |
Apr 16, 2024 | 4.00 | 4.11 | 3.90 | 4.04 | 25139.00 |
Apr 15, 2024 | 3.98 | 4.19 | 3.857 | 4.10 | 44816.00 |
Apr 12, 2024 | 3.80 | 4.13 | 3.80 | 4.10 | 30866.00 |
Apr 11, 2024 | 4.00 | 4.00 | 3.52 | 3.89 | 34247.00 |
Apr 10, 2024 | 4.17 | 4.17 | 3.84 | 3.99 | 38481.00 |
Apr 09, 2024 | 4.00 | 4.110 | 3.85 | 3.96 | 36207.00 |
Apr 08, 2024 | 3.70 | 4.11 | 3.70 | 4.09 | 88525.00 |
Apr 05, 2024 | 3.65 | 3.85 | 3.59 | 3.69 | 45188.00 |
Apr 04, 2024 | 3.71 | 3.846 | 3.65 | 3.65 | 41978.00 |
Apr 03, 2024 | 3.88 | 4.199 | 3.48 | 3.60 | 162486.0 |
Apr 02, 2024 | 3.40 | 3.90 | 3.15 | 3.88 | 310637.0 |
Apr 01, 2024 | 3.20 | 3.446 | 3.08 | 3.23 | 23332.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.90
Minimum
Mar 06 2024
126.80
Maximum
Nov 04 2021
31.02
Average
21.80
Median
Price Benchmarks
DBV Technologies SA | 0.6669 |
Ascendis Pharma A/S | 137.20 |
Cellectis SA | 2.99 |
Adaptimmune Therapeutics PLC | 1.19 |
Akari Therapeutics PLC | 1.36 |
Price Related Metrics
Earnings Yield | -205.1% |
Market Cap | 20.60M |